A study of over 500 trials, which included over 116,000 individuals, analyzed 21 different antidepressants used to treat depression in adults. Within head-to-head studies, some of the most effective ...

The world’s largest genetic study into depression has uncovered life-changing discoveries that will revolutionise treatments and spark a rethink on the use of current drugs.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Very early indications from the study show that drugs used to treat chronic pain and the sleep disorder narcolepsy could potentially be repurposed to treat depression. Since 2017 the international ...

The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...

While antipsychotics can be effective for some patients, they come with well-known side effects, including an increased risk ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

New research has revealed nearly 300 previously unknown genetic links to depression, in the world’s largest and most diverse ...